Physician profile
Paul Johnson
NPI 1992062855
$4,139.77
in general payments reported to CMS, 2019-2025
11 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $132 · 2022: $602 · 2023: $2,401 · 2024: $490 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584 · Education: $1,000 · Travel and Lodging: $804 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.47 |
| Education | $1,000.00 |
| Travel and Lodging | $804.13 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,627.89 | 2023 | Da Vinci Surgical System |
| Medtronic, INC. | $794.15 | 2022-2025 | Interstim, Infinity Occipitocervical Upper Thoracic System |
| Stryker Corporation | $566.85 | 2023 | 1788 |
| Myriad Genetic Laboratories, INC. | $393.38 | 2024-2025 | Myrisk |
| Abbott Laboratories | $258.72 | 2022-2025 | Diamondback Peripheral |
| Boston Scientific Corporation | $132.48 | 2020 | |
| Rti Surgical, INC | $121.41 | 2024 | |
| Solventum Corporation | $116.40 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Glaxosmithkline, LLC. | $81.04 | 2023 | |
| Biotissue Holdings INC. | $32.90 | 2025 | |
| Thd America, INC. | $14.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.